secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-05-18T12:32:42+00:00
Accession:  0001801170-26-000128
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health publishes supplemental Q&A for Q1 2026; no specific financial details in filing excerpt
--------------------------------------------------------------------------------

- Company furnished a supplemental Q&A document responding to shareholder questions about Q1 2026 earnings.
- No numerical data, guidance changes, or material updates are present in the provided exhibit excerpt.
- CEO Andrew Toy reiterated commitment to transparency and shareholder engagement.
- Document is available on the investor relations section of Clover Health's website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/0001801170-26-000128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/clov-20260518.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer